NNVC

NANOVIRICIDES INC

NNVC·630087302·US·Common Stock·Healthcare - Biotechnology

NNVC (NANOVIRICIDES INC) is held by 24 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($466,467), GEODE CAPITAL MANAGEMENT, LLC ($205,611), UBS Group AG ($194,583). Net institutional sentiment: Mixed.

24
Holders
Avg rating(3 Elite)
$1.5M
Total Value
60% (29)
Fund Consensus
12 buying - 8 selling

No verdict yet — fewer than 2 funds hold NNVC.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
511,477$466,4670.0%+60.64%
37
Increased
225,381(+29.3%)$205,6110.0%-47.41%
20
Increased
213,359(+556.2%)$194,5830.0%+50.67%
25
Unchanged
158,752$144,7980.0%+1.34%
0
Decreased
134,900(-22.2%)$123,0420.0%-14.63%
0
Increased
99,031(+90.9%)$90,3260.0%+26.74%
23
New
90,060$82,1350.0%+60.64%
33
New
58,138$53,0280.0%+60.64%
29
Unchanged
54,206$49,4410.0%+45.44%
0
Increased
35,432(+87.6%)$32,3180.0%+42.63%
31
Unchanged
24,256$22,1240.0%-67.71%
0
Decreased
23,755(-80.8%)$21,6670.0%+37.27%
0
Increased
7,650(+60.4%)$6,9610.0%+11.55%
16
New
3,712$3,3850.0%+60.64%
21
Unchanged
3,000$2,7180.0%+37.27%
0
Unchanged
3,000$2,6100.0%+37.05%
0
Decreased
2,616(-86.0%)$2,3860.0%+33.24%
0
Unchanged
1,024$9340.0%+1.34%
0
New
500$4770.0%+60.64%
17
Unchanged
260$2440.0%-12.21%
0

Showing 1-20 of 29

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used